IGF-1LR3.

IGF-1 LR3 is a long arginine 3 IGF-1, a recombinant IGF-1 analog with an N-terminal extension and Arg3 substitution. With the molecular formula C₄₀₀H₆₂₅N₁₁₁O₁₁₅S₆ and a molecular weight of 9111.6 g/mo...

$61.00

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for IGF-1LR3.

Receptor interaction

IGF-1 Receptor

Published research demonstrates IGF-1 LR3 modulates targeted signaling cascades within cell tissue models.

Signaling cascade

PI3K/AKT Signaling Pathway

In cellular environments, IGF-1 LR3 exhibits selective binding and corresponding pathway activation.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on IGF-1LR3 molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of IGF-1LR3 in standardized assay systems.

Preclinical

IGF-1LR3 structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of IGF-1LR3 in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring